CB
Curon Biopharmaceutical
Curon Biopharma specializes in developing targeted biopharmaceuticals that utilize monoclonal antibodies to treat autoimmune diseases. The company addresses the need for more effective therapies by enhancing patient outcomes through precision medicine tailored to individual immune responses.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Curon Biopharma specializes in developing targeted biopharmaceuticals that utilize monoclonal antibodies to treat autoimmune diseases. The company addresses the need for more effective therapies by enhancing patient outcomes through precision medicine tailored to individual immune responses.